A new trading day began on Monday, with Avidity Biosciences Inc (NASDAQ: RNA) stock price up 6.29% from the previous day of trading, before settling in for the closing price of $22.73. RNA’s price has ranged from $4.82 to $27.66 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 148.90% over the past five years. Meanwhile, its annual earnings per share averaged -10.57%. With a float of $71.37 million, this company’s outstanding shares have now reached $79.28 million.
Let’s look at the performance matrix of the company that is accounted for 253 employees.
Avidity Biosciences Inc (RNA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Avidity Biosciences Inc is 10.48%, while institutional ownership is 98.39%. The most recent insider transaction that took place on Apr 19 ’24, was worth 114,123. In this transaction Director of this company sold 5,000 shares at a rate of $22.82, taking the stock ownership to the 14,830 shares. Before that another transaction happened on Apr 03 ’24, when Company’s Director sold 20,000 for $27.11, making the entire transaction worth $542,214. This insider now owns 253,872 shares in total.
Avidity Biosciences Inc (RNA) Latest Financial update
In its latest quarterly report, released on 12/31/2023, the company reported earnings of -$0.79 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.57% per share during the next fiscal year.
Avidity Biosciences Inc (NASDAQ: RNA) Trading Performance Indicators
Here are Avidity Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 201.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.90, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -3.49 in one year’s time.
Technical Analysis of Avidity Biosciences Inc (RNA)
Avidity Biosciences Inc (NASDAQ: RNA) saw its 5-day average volume 0.9 million, a negative change from its year-to-date volume of 1.18 million. As of the previous 9 days, the stock’s Stochastic %D was 24.14%. Additionally, its Average True Range was 1.52.
During the past 100 days, Avidity Biosciences Inc’s (RNA) raw stochastic average was set at 83.38%, which indicates a significant increase from 42.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.39% in the past 14 days, which was lower than the 79.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $21.03, while its 200-day Moving Average is $11.41. Nevertheless, the first resistance level for the watch stands at $25.07 in the near term. At $25.99, the stock is likely to face the second major resistance level. The third major resistance level sits at $27.15. If the price goes on to break the first support level at $23.00, it is likely to go to the next support level at $21.84. The third support level lies at $20.92 if the price breaches the second support level.
Avidity Biosciences Inc (NASDAQ: RNA) Key Stats
With a market capitalization of 1.93 billion, the company has a total of 79,719K Shares Outstanding. Currently, annual sales are 9,560 K while annual income is -212,220 K. The company’s previous quarter sales were 2,190 K while its latest quarter income was -60,440 K.
